Improvement in social and cognitive functioning associated with paliperidone extended-release treatment in patients with schizophrenia: a 24-week, single arm, open-label study

PURPOSE: This single-arm, open-label study aimed to explore the effects of extended-release paliperidone on social and cognitive function in patients with schizophrenia. METHODS: Paliperidone extended-release (flexible dose ranging from 3 to 12 mg/day orally) was administered for 24 weeks in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Chuan, Yao, Shu Qiao, Xu, Yi Feng, Shi, Jian Guo, Xu, Xiu Feng, Zhang, Cong Pei, Jin, Hua, Yu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006669/
https://www.ncbi.nlm.nih.gov/pubmed/27601904
http://dx.doi.org/10.2147/NDT.S112542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006669/
https://www.ncbi.nlm.nih.gov/pubmed/27601904
http://dx.doi.org/10.2147/NDT.S112542

Ejemplares similares